United Therapeutics Aktie

Kaufen
Verkaufen
343,40 EUR +1,70 EUR +0,50 %
361,13 USD +1,37 USD +0,38 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 15,36 Mrd. EUR

KGV 11,10 Div. Rendite 0,00%

WKN 923818

ISIN US91307C1027

Symbol UTHR


United Therapeutics Aktie Analyse

19.01.17 United Therapeutics Hold Standpoint Research
15.06.16 United Therapeutics Neutral H.C. Wainwright & Co.
11.04.16 United Therapeutics Sector Perform RBC Capital Markets
29.07.15 United Therapeutics Sector Perform RBC Capital Markets
29.04.15 United Therapeutics Sector Perform RBC Capital Markets
04.03.15 United Therapeutics Hold Standpoint Research
03.11.14 United Therapeutics Hold Argus Research Company
25.07.12 United Therapeutics sector perform RBC Capital Markets
26.03.12 United Therapeutics sector perform RBC Capital Markets
14.06.11 United Therapeutics sector perform RBC Capital Markets
16.02.11 United Therapeutics neutral Wedbush Morgan Securities Inc.
15.02.11 United Therapeutics neutral Wedbush Morgan Securities Inc.
27.10.10 United Therapeutics neutral Wedbush Morgan Securities Inc.
23.04.10 United Therapeutics halten Wedbush Morgan Securities Inc.
03.08.09 United Therapeutics neutral JP Morgan Chase & Co.
31.07.09 United Therapeutics neutral Wedbush Morgan Securities Inc.
20.04.09 United Therapeutics equal weight Barclays Capital
12.03.09 United Therapeutics neutral FTN Midwest Securities Corp.
19.11.08 United Therapeutics neutral Piper Jaffray & Co.
18.11.08 United Therapeutics hold Deutsche Bank AG
07.07.08 United Therapeutics hold Stanford Financial Group, Inc.
06.12.07 United Therapeutics hold Brean Murray, Carret & Co., LLC
20.02.06 United Therapeutics market perform CE Unterberg, Towbin
08.08.05 United Therapeutics Market Perform Rodman & Renshaw
27.05.05 United Therapeutics market perform Leerink Swann
27.05.05 United Therapeutics Market Peform Leerink Swann